ABBV · News · 20260824N

Acquisition / Partnership / Divestiture

AbbVie Inc. · 2026-08-24 · Importance 31 · Surprise 42

AbbVie is anticipating the acquisition of Apogee Therapeutics. The Apogee transaction prompted AbbVie to lower its full-year adjusted EPS guidance. The digest does not provide the acquisition consideration, closing timeline, or expected revenue contribution.

Key facts

• AbbVie anticipates an acquisition of Apogee Therapeutics (described as the "anticipated acquisition of Apogee Therapeutics"). source